GLP-1 S
Single-Agonist GLP-1 Research Compound - Single-agonist GLP-1 research compound.
GLP-1 S is a single-agonist research compound targeting the GLP-1 receptor, one of the most studied targets in metabolic and appetite-signaling research.
Single GLP-1 receptor agonists are the most extensively characterized class in metabolic research, providing a well-understood baseline against which multi-agonist compounds are compared. GLP-1 S is studied as a reference point for incretin and satiety signaling.
GLP-1 S specifications
- Molecular weight
- 4113.58 g/mol
- Sequence
- GLP-1 receptor agonist peptide
- Residues
- 31-residue acylated GLP-1 analog
- Presentation
- Lyophilized powder
- Documented purity
- 99.62% by HPLC
- Available sizes
- 20mg ($80)
- Archived COA lots
- 2
- Intended use
- Laboratory research use only. Not for human or veterinary use.
Studied pathways
- GLP-1 receptor - Reference agonist for study of glucose-dependent insulin signaling and satiety pathways.
Reported mechanisms in the literature
- Incretin signaling - A single-agonist research compound at the GLP-1 receptor, one of the most-studied targets in metabolic and appetite-signaling research. (Drucker et al.)
- Glucose-dependent response - Studied for glucose-dependent insulin-signaling and satiety pathways in metabolic-research models. (Preclinical literature)
What GLP-1 S is researched for
- Appetite & satiety - Studied as a reference GLP-1 agonist for satiety-signaling endpoints in metabolic research. (Drucker et al.)
- Insulin response - Investigated for glucose-dependent insulinotropic signaling. (Preclinical literature)
GLP-1 S certificates of analysis on file
Every lot below was tested by an independent laboratory and the full report is published as a PDF. Purity is shown exactly as the report states it. The same records are searchable in the COA library and can be checked on the lot verification page.
| Lot | Tested | Size | Laboratory | HPLC purity | Identity | Certificate |
|---|---|---|---|---|---|---|
| GLP1-092526-20 | 22 Oct 2026 | 20mg | ILS Laboratories | 99.69% | Confirmed (HPLC retention time) | COA PDF |
| H1HVXK | 10 Oct 2026 | 15mg | Freedom Diagnostics | 99.62% | Confirmed (LC-MS/MS) | COA PDF |
Published literature on GLP-1 S
The mechanisms above trace to peer-reviewed studies indexed on PubMed. These are independent third-party publications, not Aspect Peptides claims. Browse indexed research on PubMed.
GLP-1 S frequently asked questions
What is GLP-1 S?
A single-agonist research compound targeting the GLP-1 receptor, studied in metabolic and appetite-regulation research.
Is it approved for human use?
No. It is supplied for laboratory research only and is not a medicine or supplement.
Where is its molecular data?
Structural identifiers for this research formulation are documented on the lot COA.
Documented to 99.62% purity by HPLC · third-party COA every lot · from $80 · For laboratory research use only.
Related Metabolic compounds
- GLP-3 RT - Triple-receptor GLP research compound (GLP-1/GIP/glucagon class).
- GLP-2 TZ - Dual GIP/GLP-1 receptor co-agonist studied in glucose-handling and energy-balance research.
- Cagrilintide - Acylated amylin analogue studied for amylin and calcitonin receptor signaling.
- GLP-3 RT + Cagri - GLP-3 RT (10mg) co-formulated with Cagrilintide (2mg) in one vial.
- 5-Amino-1MQ - Small-molecule NNMT inhibitor studied in metabolism research.
- MOTS-c - Mitochondrial-derived peptide studied for metabolic regulation.